117 related articles for article (PubMed ID: 15147979)
1. EWS differentially activates transcription of the Brn-3a long and short isoform mRNAs from distinct promoters.
Thomas GR; Faulkes DJ; Gascoyne D; Latchman DS
Biochem Biophys Res Commun; 2004 Jun; 318(4):1045-51. PubMed ID: 15147979
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of Oct-4 activity by Ewing's sarcoma protein.
Lee J; Rhee BK; Bae GY; Han YM; Kim J
Stem Cells; 2005; 23(6):738-51. PubMed ID: 15917470
[TBL] [Abstract][Full Text] [Related]
3. The pro-oncoprotein EWS (Ewing's Sarcoma protein) interacts with the Brn-3a POU transcription factor and inhibits its ability to activate transcription.
Thomas GR; Latchman DS
Cancer Biol Ther; 2002; 1(4):428-32. PubMed ID: 12432261
[TBL] [Abstract][Full Text] [Related]
4. Elevated expression of the Brn-3a and Brn-3b transcription factors in systemic lupus erythematosus correlates with antibodies to Brn-3 and overexpression of Hsp90.
Ripley BJ; Rahman MA; Isenberg DA; Latchman DS
Arthritis Rheum; 2005 Apr; 52(4):1171-9. PubMed ID: 15818685
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the isoforms of MOVO zinc finger protein, a mouse homologue of Drosophila Ovo, as transcription factors.
Unezaki S; Nishizawa M; Okuda-Ashitaka E; Masu Y; Mukai M; Kobayashi S; Sawamoto K; Okano H; Ito S
Gene; 2004 Jul; 336(1):47-58. PubMed ID: 15225875
[TBL] [Abstract][Full Text] [Related]
6. The homeotic protein Six3 is a coactivator of the nuclear receptor NOR-1 and a corepressor of the fusion protein EWS/NOR-1 in human extraskeletal myxoid chondrosarcomas.
Laflamme C; Filion C; Bridge JA; Ladanyi M; Goldring MB; Labelle Y
Cancer Res; 2003 Jan; 63(2):449-54. PubMed ID: 12543801
[TBL] [Abstract][Full Text] [Related]
7. Functional interaction between Brn-3a and Src-1 co-activates Brn-3a-mediated transactivation.
Dennis JH; Budhram-Mahadeo V; Latchman DS
Biochem Biophys Res Commun; 2002 Jun; 294(2):487-95. PubMed ID: 12051737
[TBL] [Abstract][Full Text] [Related]
8. Activation and repression of gene expression by POU family transcription factors.
Latchman DS
Philos Trans R Soc Lond B Biol Sci; 1996 Apr; 351(1339):511-5. PubMed ID: 8735273
[TBL] [Abstract][Full Text] [Related]
9. The Brn-3a transcription factor plays a key role in regulating the growth of cervical cancer cells in vivo.
Ndisang D; Budhram-Mahadeo V; Pedley B; Latchman DS
Oncogene; 2001 Aug; 20(35):4899-903. PubMed ID: 11521202
[TBL] [Abstract][Full Text] [Related]
10. The effects of Brn-3a on neuronal differentiation and apoptosis are differentially modulated by EWS and its oncogenic derivative EWS/Fli-1.
Gascoyne DM; Thomas GR; Latchman DS
Oncogene; 2004 May; 23(21):3830-40. PubMed ID: 15021903
[TBL] [Abstract][Full Text] [Related]
11. Gene expression of the POU factor Brn-3a is regulated by two different promoters.
Frass B; Vassen L; Möröy T
Biochim Biophys Acta; 2002 Dec; 1579(2-3):207-13. PubMed ID: 12427558
[TBL] [Abstract][Full Text] [Related]
12. The Brn-3a POU family transcription factor stimulates p53 gene expression in human and mouse tumour cells.
Budhram-Mahadeo V; Morris P; Ndisang D; Irshad S; Lozano G; Pedley B; Latchman DS
Neurosci Lett; 2002 Dec; 334(1):1-4. PubMed ID: 12431761
[TBL] [Abstract][Full Text] [Related]
13. Brn-3c (POU4F3) regulates BDNF and NT-3 promoter activity.
Clough RL; Sud R; Davis-Silberman N; Hertzano R; Avraham KB; Holley M; Dawson SJ
Biochem Biophys Res Commun; 2004 Nov; 324(1):372-81. PubMed ID: 15465029
[TBL] [Abstract][Full Text] [Related]
14. The Brn-3b POU family transcription factor represses expression of the BRCA-1 anti-oncogene in breast cancer cells.
Budhram-Mahadeo V; Ndisang D; Ward T; Weber BL; Latchman DS
Oncogene; 1999 Nov; 18(48):6684-91. PubMed ID: 10597274
[TBL] [Abstract][Full Text] [Related]
15. A minimal Bcl-x promoter is activated by Brn-3a and repressed by p53.
Sugars KL; Budhram-Mahadeo V; Packham G; Latchman DS
Nucleic Acids Res; 2001 Nov; 29(22):4530-40. PubMed ID: 11713302
[TBL] [Abstract][Full Text] [Related]
16. Mxi1-SRalpha: a novel Mxi1 isoform with enhanced transcriptional repression potential.
Dugast-Darzacq C; Pirity M; Blanck JK; Scherl A; Schreiber-Agus N
Oncogene; 2004 Nov; 23(55):8887-99. PubMed ID: 15467743
[TBL] [Abstract][Full Text] [Related]
17. Involvement of mPOU (Brn-5), a class VI POU protein, in the gene expression of Pit-1 as well as PRL.
Toda K; Yamamoto D; Fumoto M; Ikeshita N; Herningtyas EH; Iida K; Takahashi Y; Kaji H; Chihara K; Okimura Y
Mol Cell Endocrinol; 2008 Jan; 280(1-2):20-9. PubMed ID: 17933456
[TBL] [Abstract][Full Text] [Related]
18. Interaction of Brn3a and HIPK2 mediates transcriptional repression of sensory neuron survival.
Wiggins AK; Wei G; Doxakis E; Wong C; Tang AA; Zang K; Luo EJ; Neve RL; Reichardt LF; Huang EJ
J Cell Biol; 2004 Oct; 167(2):257-67. PubMed ID: 15492043
[TBL] [Abstract][Full Text] [Related]
19. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.
García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J
Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936
[TBL] [Abstract][Full Text] [Related]
20. Role of the Brn-3 family of POU-domain genes in the development of the auditory/vestibular, somatosensory, and visual systems.
Xiang M; Gan L; Li D; Zhou L; Chen ZY; Wagner D; O'Malley BW; Klein W; Nathans J
Cold Spring Harb Symp Quant Biol; 1997; 62():325-36. PubMed ID: 9598366
[No Abstract] [Full Text] [Related]
[Next] [New Search]
